Genmab A GMAB
NASDAQ GMAB
$43.79 +3.79 (+9.48%)
At close: Oct 23, 2026 · 4:00 PM EDT

Genmab A (GMAB) Tax Rate (2024 - 2025)

Updated

Genmab A (GMAB) recorded Tax Rate of -2.71% in the quarter ended Jun 30, 2026.

Analysis

Genmab A (GMAB) Tax Rate (2024 - 2025) Analysis & Trends

On a TTM basis, Genmab A's Tax Rate came in at 81.81% as of Jun 30, 2026; for the year ended Dec 31, 2025, it was 20.02%, up 5.46 percentage points from the prior year.

  • Annual Tax Rate has a three-year change of -160.96 percentage points (years ended Dec 2022 to Dec 2025).
  • Across earlier years, Tax Rate came in at 14.56% in the year ended Dec 31, 2024 (-8.21 pp), 22.77% in the year ended Dec 31, 2023 (-158.21 pp) and 180.98% in the year ended Dec 31, 2022.
  • The figure for the quarter ended Jun 30, 2026 is the highest quarterly Tax Rate since the quarter ended Jun 30, 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 23.27%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn -
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 15.47%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 23.71%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 10.40%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 14.20%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn -
10 Genmab A 2.81 Bn -2.56 Bn 1.07 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 20.57%
Jun 30, 2024 33.88%
API Access

Genmab A Tax Rate API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-rate&ticker=GMAB&period=max&api_key=YOUR_API_KEY